annual EBITDA:
-$450.13M-$89.73M(-24.90%)Summary
- As of today (September 17, 2025), MDGL annual EBITDA is -$450.13 million, with the most recent change of -$89.73 million (-24.90%) on December 31, 2024.
- During the last 3 years, MDGL annual EBITDA has fallen by -$208.68 million (-86.43%).
- MDGL annual EBITDA is now -642.30% below its all-time high of $83.00 million, reached on December 31, 2009.
Performance
MDGL EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$46.83M+$32.11M(+40.68%)Summary
- As of today (September 17, 2025), MDGL quarterly EBITDA is -$46.83 million, with the most recent change of +$32.11 million (+40.68%) on June 30, 2025.
- Over the past year, MDGL quarterly EBITDA has increased by +$115.44 million (+71.14%).
- MDGL quarterly EBITDA is now -139.42% below its all-time high of $118.78 million, reached on September 30, 2009.
Performance
MDGL quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$308.40M+$115.44M(+27.24%)Summary
- As of today (September 17, 2025), MDGL TTM EBITDA is -$308.40 million, with the most recent change of +$115.44 million (+27.24%) on June 30, 2025.
- Over the past year, MDGL TTM EBITDA has increased by +$221.18 million (+41.76%).
- MDGL TTM EBITDA is now -422.03% below its all-time high of $95.77 million, reached on March 31, 2010.
Performance
MDGL TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
MDGL EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -24.9% | +71.1% | +41.8% |
| 3 y3 years | -86.4% | +33.3% | -20.8% |
| 5 y5 years | -374.5% | +6.8% | -116.9% |
MDGL EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -86.4% | at low | at high | +71.1% | -20.8% | +43.6% |
| 5 y | 5-year | -374.5% | at low | at high | +71.1% | -116.9% | +43.6% |
| alltime | all time | -642.3% | at low | -139.4% | +71.1% | -422.0% | +43.6% |
MDGL EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$46.83M(-40.7%) | -$308.40M(-27.2%) |
| Mar 2025 | - | -$78.93M(+18.5%) | -$423.84M(-14.7%) |
| Dec 2024 | -$450.13M(+24.9%) | -$66.63M(-42.6%) | -$496.78M(-9.2%) |
| Sep 2024 | - | -$116.01M(-28.5%) | -$547.18M(+3.3%) |
| Jun 2024 | - | -$162.27M(+6.8%) | -$529.57M(+16.7%) |
| Mar 2024 | - | -$151.87M(+29.8%) | -$453.63M(+19.4%) |
| Dec 2023 | -$360.39M(+23.9%) | -$117.03M(+18.9%) | -$379.97M(+9.2%) |
| Sep 2023 | - | -$98.40M(+14.0%) | -$348.11M(+5.5%) |
| Jun 2023 | - | -$86.32M(+10.4%) | -$330.00M(+5.1%) |
| Mar 2023 | - | -$78.21M(-8.2%) | -$313.84M(+7.1%) |
| Dec 2022 | -$290.92M(+20.5%) | -$85.17M(+6.1%) | -$293.10M(+7.6%) |
| Sep 2022 | - | -$80.29M(+14.4%) | -$272.43M(+6.8%) |
| Jun 2022 | - | -$70.16M(+22.1%) | -$255.20M(+3.4%) |
| Mar 2022 | - | -$57.48M(-10.9%) | -$246.69M(+1.9%) |
| Dec 2021 | -$241.44M(+17.1%) | -$64.50M(+2.3%) | -$242.08M(+2.1%) |
| Sep 2021 | - | -$63.06M(+2.3%) | -$237.02M(+1.9%) |
| Jun 2021 | - | -$61.65M(+16.6%) | -$232.63M(+5.2%) |
| Mar 2021 | - | -$52.87M(-11.1%) | -$221.19M(+7.3%) |
| Dec 2020 | -$206.20M(+117.4%) | -$59.44M(+1.3%) | -$206.20M(+16.7%) |
| Sep 2020 | - | -$58.67M(+16.8%) | -$176.69M(+24.3%) |
| Jun 2020 | - | -$50.21M(+32.6%) | -$142.19M(+24.0%) |
| Mar 2020 | - | -$37.88M(+26.6%) | -$114.65M(+20.9%) |
| Dec 2019 | -$94.86M(+133.7%) | -$29.93M(+23.8%) | -$94.86M(+19.5%) |
| Sep 2019 | - | -$24.17M(+6.6%) | -$79.36M(+19.3%) |
| Jun 2019 | - | -$22.68M(+25.3%) | -$66.50M(+28.8%) |
| Mar 2019 | - | -$18.09M(+25.4%) | -$51.63M(+27.2%) |
| Dec 2018 | -$40.59M(+26.9%) | -$14.43M(+27.6%) | -$40.59M(+15.9%) |
| Sep 2018 | - | -$11.31M(+45.0%) | -$35.01M(+8.3%) |
| Jun 2018 | - | -$7.80M(+10.7%) | -$32.33M(-1.9%) |
| Mar 2018 | - | -$7.05M(-20.4%) | -$32.96M(+3.0%) |
| Dec 2017 | -$31.98M(+27.1%) | -$8.85M(+2.6%) | -$31.98M(+38.3%) |
| Sep 2017 | - | -$8.63M(+2.3%) | -$23.13M(-18.7%) |
| Jun 2017 | - | -$8.43M(+38.8%) | -$28.47M(+21.5%) |
| Mar 2017 | - | -$6.08M(-56.5%) | -$23.43M(-5.4%) |
| Dec 2016 | -$25.18M(+678.7%) | - | - |
| Sep 2016 | - | -$13.96M(+311.4%) | -$24.77M(+112.2%) |
| Jun 2016 | - | -$3.39M(-47.0%) | -$11.67M(-57.7%) |
| Mar 2016 | - | -$6.40M(+529.8%) | -$27.61M(-33.3%) |
| Dec 2015 | -$3.23M(-96.1%) | -$1.02M(+18.2%) | -$41.38M(-31.1%) |
| Sep 2015 | - | -$860.00K(-95.6%) | -$60.08M(-23.5%) |
| Jun 2015 | - | -$19.34M(-4.1%) | -$78.51M(-2.7%) |
| Mar 2015 | - | -$20.16M(+2.2%) | -$80.70M(-3.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2014 | -$83.28M(-4.3%) | -$19.73M(+2.3%) | -$83.28M(-4.1%) |
| Sep 2014 | - | -$19.28M(-10.4%) | -$86.85M(-2.6%) |
| Jun 2014 | - | -$21.53M(-5.3%) | -$89.22M(-0.5%) |
| Mar 2014 | - | -$22.74M(-2.4%) | -$89.62M(+3.0%) |
| Dec 2013 | -$87.04M(+44.6%) | -$23.30M(+7.6%) | -$87.04M(+7.0%) |
| Sep 2013 | - | -$21.65M(-1.3%) | -$81.33M(+9.8%) |
| Jun 2013 | - | -$21.94M(+8.8%) | -$74.05M(+11.8%) |
| Mar 2013 | - | -$20.16M(+14.6%) | -$66.25M(+9.4%) |
| Dec 2012 | -$60.20M(+36.9%) | -$17.59M(+22.4%) | -$60.57M(+14.4%) |
| Sep 2012 | - | -$14.37M(+1.7%) | -$52.93M(+5.0%) |
| Jun 2012 | - | -$14.13M(-2.4%) | -$50.43M(+5.2%) |
| Mar 2012 | - | -$14.48M(+45.6%) | -$47.92M(+9.0%) |
| Dec 2011 | -$43.97M(+25.7%) | -$9.95M(-16.2%) | -$43.97M(+4.9%) |
| Sep 2011 | - | -$11.87M(+2.1%) | -$41.92M(+5.3%) |
| Jun 2011 | - | -$11.63M(+10.4%) | -$39.81M(+8.3%) |
| Mar 2011 | - | -$10.53M(+33.2%) | -$36.75M(+5.1%) |
| Dec 2010 | -$34.97M(-142.1%) | -$7.90M(-19.0%) | -$34.97M(+4.3%) |
| Sep 2010 | - | -$9.76M(+14.0%) | -$33.53M(-135.3%) |
| Jun 2010 | - | -$8.56M(-2.1%) | $95.01M(-0.8%) |
| Mar 2010 | - | -$8.74M(+35.2%) | $95.77M(+13.7%) |
| Dec 2009 | $83.00M(-191.2%) | -$6.46M(-105.4%) | $84.24M(+28.6%) |
| Sep 2009 | - | $118.78M(-1622.4%) | $65.52M(-183.0%) |
| Jun 2009 | - | -$7.80M(-61.5%) | -$78.98M(-15.5%) |
| Mar 2009 | - | -$20.27M(-19.5%) | -$93.49M(+2.8%) |
| Dec 2008 | -$90.99M(+44.7%) | -$25.18M(-2.1%) | -$90.99M(+12.0%) |
| Sep 2008 | - | -$25.72M(+15.2%) | -$81.27M(+15.9%) |
| Jun 2008 | - | -$22.32M(+25.6%) | -$70.12M(+8.9%) |
| Mar 2008 | - | -$17.77M(+14.9%) | -$64.42M(+2.5%) |
| Dec 2007 | -$62.87M(+13.3%) | -$15.46M(+6.2%) | -$62.86M(+5.5%) |
| Sep 2007 | - | -$14.57M(-12.3%) | -$59.58M(+1.5%) |
| Jun 2007 | - | -$16.62M(+2.5%) | -$58.68M(+4.7%) |
| Mar 2007 | - | -$16.21M(+33.1%) | -$56.05M(+1.0%) |
| Dec 2006 | -$55.50M(-19.2%) | -$12.18M(-10.9%) | -$55.50M(+28.1%) |
| Sep 2006 | - | -$13.67M(-2.2%) | -$43.32M(+46.1%) |
| Jun 2006 | - | -$13.98M(-10.7%) | -$29.65M(+89.3%) |
| Mar 2006 | - | -$15.66M(-13.3%) | -$15.66M(-13.3%) |
| Dec 2005 | -$68.72M(+56.9%) | - | - |
| Mar 2005 | - | -$18.07M(+231.4%) | -$18.07M(+231.4%) |
| Dec 2004 | -$43.80M(+60.5%) | - | - |
| Mar 2004 | - | -$5.45M | -$5.45M |
| Dec 2003 | -$27.29M(+274.2%) | - | - |
| Dec 2002 | -$7.29M(+1718.5%) | - | - |
| Dec 2001 | -$401.00K | - | - |
FAQ
- What is Madrigal Pharmaceuticals, Inc. annual EBITDA?
- What is the all time high annual EBITDA for Madrigal Pharmaceuticals, Inc.?
- What is Madrigal Pharmaceuticals, Inc. annual EBITDA year-on-year change?
- What is Madrigal Pharmaceuticals, Inc. quarterly EBITDA?
- What is the all time high quarterly EBITDA for Madrigal Pharmaceuticals, Inc.?
- What is Madrigal Pharmaceuticals, Inc. quarterly EBITDA year-on-year change?
- What is Madrigal Pharmaceuticals, Inc. TTM EBITDA?
- What is the all time high TTM EBITDA for Madrigal Pharmaceuticals, Inc.?
- What is Madrigal Pharmaceuticals, Inc. TTM EBITDA year-on-year change?
What is Madrigal Pharmaceuticals, Inc. annual EBITDA?
The current annual EBITDA of MDGL is -$450.13M
What is the all time high annual EBITDA for Madrigal Pharmaceuticals, Inc.?
Madrigal Pharmaceuticals, Inc. all-time high annual EBITDA is $83.00M
What is Madrigal Pharmaceuticals, Inc. annual EBITDA year-on-year change?
Over the past year, MDGL annual EBITDA has changed by -$89.73M (-24.90%)
What is Madrigal Pharmaceuticals, Inc. quarterly EBITDA?
The current quarterly EBITDA of MDGL is -$46.83M
What is the all time high quarterly EBITDA for Madrigal Pharmaceuticals, Inc.?
Madrigal Pharmaceuticals, Inc. all-time high quarterly EBITDA is $118.78M
What is Madrigal Pharmaceuticals, Inc. quarterly EBITDA year-on-year change?
Over the past year, MDGL quarterly EBITDA has changed by +$115.44M (+71.14%)
What is Madrigal Pharmaceuticals, Inc. TTM EBITDA?
The current TTM EBITDA of MDGL is -$308.40M
What is the all time high TTM EBITDA for Madrigal Pharmaceuticals, Inc.?
Madrigal Pharmaceuticals, Inc. all-time high TTM EBITDA is $95.77M
What is Madrigal Pharmaceuticals, Inc. TTM EBITDA year-on-year change?
Over the past year, MDGL TTM EBITDA has changed by +$221.18M (+41.76%)